-
EP2170848
European procedure
Extract from the Register of European Patents
EP About this file: EP2170848
| EP2170848 - PYRAZINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF LUNG DISEASES [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 28.08.2015 Database last updated on 09.07.2024 | Most recent event Tooltip | 28.08.2015 | No opposition filed within time limit | published on 30.09.2015 [2015/40] | Applicant(s) | For all designated states AstraZeneca AB 151 85 Södertälje / SE | [2010/14] | Inventor(s) | 01 /
BROUGH, Stephen AstraZeneca R&D Charnwood Bakewell Road Loughborough Leicestershire LE11 5RH / GB | 02 /
EVANS, Richard AstraZeneca R&D Charnwood Bakewell Road Loughborough Leicestershire LE11 5RH / GB | 03 /
LUKER, Timothy, Jon AstraZeneca R&D Charnwood Bakewell Road Loughborough Leicestershire LE11 5RH / GB | 04 /
RAUBO, Piotr AstraZeneca R&D Charnwood Bakewell Road Loughborough Leicestershire LE11 5RH / GB | [2014/43] |
| Former [2010/14] | 01 /
BROUGH, Stephen AstraZeneca R&D Charnwood Bakewell Road Loughborough Leicestershire LE11 5RH / GB | ||
| 02 /
EVANS, Richard AstraZeneca R&D Charnwood Bakewell Road Loughborough Leicestershire LE11 5RH / GB | |||
| 03 /
LUKER, Timothy, Jon AstraZeneca R&D Charnwood Bakewell Road Loughborough Leicestershire LE11 5RH / GB | |||
| 04 /
RAUBO, Piotr AstraZeneca R&D Charnwood Bakewell Road Loughborough Leicestershire LE11 5RH / GB | Application number, filing date | 08776162.3 | 25.06.2008 | [2010/14] | WO2008GB50491 | Priority number, date | US20070946415P | 27.06.2007 Original published format: US 946415 P | US20070978167P | 08.10.2007 Original published format: US 978167 P | US20080029444 | 18.02.2008 Original published format: US 29444 | [2010/14] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2009001132 | Date: | 31.12.2008 | Language: | EN | [2009/01] | Type: | A1 Application with search report | No.: | EP2170848 | Date: | 07.04.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 31.12.2008 takes the place of the publication of the European patent application. | [2010/14] | Type: | B1 Patent specification | No.: | EP2170848 | Date: | 22.10.2014 | Language: | EN | [2014/43] | Search report(s) | International search report - published on: | EP | 31.12.2008 | Classification | IPC: | C07D241/20, C07D401/12, C07D403/04, C07D403/12, C07D413/12, A61K31/454, A61P11/06 | [2010/14] | CPC: |
C07D491/113 (EP,US);
C07D241/20 (EP,KR,US);
A61K31/454 (KR);
A61P1/04 (EP);
A61P1/08 (EP);
A61P1/16 (EP);
A61P11/00 (EP);
A61P11/02 (EP);
A61P11/06 (EP);
A61P11/08 (EP);
A61P13/08 (EP);
A61P13/10 (EP);
A61P15/00 (EP);
A61P17/00 (EP);
A61P17/04 (EP);
A61P17/06 (EP);
A61P19/00 (EP);
A61P19/02 (EP);
A61P19/10 (EP);
A61P21/00 (EP);
A61P25/00 (EP);
A61P25/06 (EP);
A61P25/28 (EP);
A61P27/02 (EP);
A61P29/00 (EP);
A61P31/12 (EP);
A61P35/00 (EP);
A61P37/06 (EP);
A61P43/00 (EP);
A61P5/00 (EP);
A61P9/00 (EP);
A61P9/10 (EP);
C07D241/08 (EP,US);
C07D401/12 (EP,US);
C07D403/04 (EP,US);
C07D403/12 (EP,KR,US);
C07D405/12 (EP,US);
C07D413/04 (EP,US);
C07D413/12 (EP,US);
C07D471/10 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/14] | Extension states | AL | 27.01.2010 | BA | 27.01.2010 | MK | 27.01.2010 | RS | 27.01.2010 | Title | German: | PYRAZINONDERIVATE UND IHRE VERWENDUNG ZUR BEHANDLUNG VON LUNGENKRANKHEITEN | [2010/14] | English: | PYRAZINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF LUNG DISEASES | [2010/14] | French: | DÉRIVÉ DE PYRAZINONE ET LEUR UTILISATION DANS LE TRAITEMENT DE MALADIES DU POUMON | [2010/14] | Entry into regional phase | 27.01.2010 | National basic fee paid | 27.01.2010 | Designation fee(s) paid | 27.01.2010 | Examination fee paid | Examination procedure | 27.01.2010 | Examination requested [2010/14] | 25.05.2012 | Despatch of a communication from the examining division (Time limit: M04) | 20.09.2012 | Reply to a communication from the examining division | 10.07.2013 | Despatch of a communication from the examining division (Time limit: M02) | 25.07.2013 | Reply to a communication from the examining division | 08.01.2014 | Communication of intention to grant the patent | 25.04.2014 | Fee for grant paid | 25.04.2014 | Fee for publishing/printing paid | 25.04.2014 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 25.05.2012 | Opposition(s) | 23.07.2015 | No opposition filed within time limit [2015/40] | Fees paid | Renewal fee | 30.06.2010 | Renewal fee patent year 03 | 30.06.2011 | Renewal fee patent year 04 | 02.07.2012 | Renewal fee patent year 05 | 01.07.2013 | Renewal fee patent year 06 | 30.06.2014 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2005054230 (CYTOPIA RES PTY LTD [AU], et al) [A] 1-15 * page 8, line 2 - page 8, line 3; examples 1-22; claim - *; | [PX] - J. F. BEREZNAK ET AL, "Preparation of pyrazinones as cellular proliferation inhibitors", CAPLUS, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, (20071227), XP002497011 [PX] 1,4,9,14 * CAPLUS-Nr.: 1008732-26-0; -61-3; -63-5; 1008733-11-6; 1008733-13-8; -48-9; -50-3; -98-9; 1008734-00-6; -86-8; -88-0; 1008735-23-6; -25-8; -74-7; -76-9; 1008736-01-3; 03-5; 1008744-49-7; column A * | [DA] - HANSON G J, "inhibitors of p38 kinase", EXPERT OPINION ON THERAPEUTIC PATENTS, INFORMA HEALTHCARE, GB, (19970101), vol. 7, no. 7, ISSN 1354-3776, pages 729 - 733, XP002086152 [DA] 1-15 * the whole document * DOI: http://dx.doi.org/10.1517/13543776.7.7.729 |